Contact Us

SEC Filings

Investor Contacts

Andrea N. Flynn, Ph.D.
Vice President, Head,
Investor Relations

investorinfo@jazzpharma.com
Ireland: +353 1 634 3211
U.S.: +1 650 496 2717

SEC Filings

Filing date	Form	Description	Filing Group	View
Jan 05, 2023	SC 13G/A	An amendment to the SC 13G filing	Other	View HTML 0000019617-23-000020.pdf 0000019617-23-000020.rtf 0000019617-23-000020.xls
Jan 26, 2023	SC 13G/A	An amendment to the SC 13G filing	Other	View HTML 0001306550-23-004315.pdf 0001306550-23-004315.rtf
Feb 09, 2023	SC 13G/A	An amendment to the SC 13G filing	Other	View HTML 0001104659-23-016260.pdf 0001104659-23-016260.rtf
Sep 11, 2023	SC 13G/A	An amendment to the SC 13G filing	Other	View HTML 0001104659-23-099621.pdf 0001104659-23-099621.rtf
Dec 19, 2013	SC TO-C	Written public communication relating to an issuer or third party tender offer	Mergers & Acquisitions	View HTML 0001193125-13-479285.pdf 0001193125-13-479285.rtf 0001193125-13-479285.xls
Dec 20, 2013	SC TO-C	Written public communication relating to an issuer or third party tender offer	Mergers & Acquisitions	View HTML 0001193125-13-479867.pdf 0001193125-13-479867.rtf 0001193125-13-479867.xls
Dec 20, 2013	SC TO-C	Written public communication relating to an issuer or third party tender offer	Mergers & Acquisitions	View HTML 0001193125-13-481243.pdf 0001193125-13-481243.rtf 0001193125-13-481243.xls
May 31, 2016	SC TO-C	Written public communication relating to an issuer or third party tender offer	Mergers & Acquisitions	View HTML 0001193125-16-607098.pdf 0001193125-16-607098.rtf 0001193125-16-607098.xls
May 31, 2016	SC TO-C	Written public communication relating to an issuer or third party tender offer	Mergers & Acquisitions	View HTML 0001193125-16-608675.pdf 0001193125-16-608675.rtf 0001193125-16-608675.xls
Dec 23, 2013	SC TO-T	Tender offer schedule and amendment filed by a third party.	Mergers & Acquisitions	View HTML 0001193125-13-481906.pdf 0001193125-13-481906.rtf 0001193125-13-481906.xls

Data provided by Kaleidoscope.